Literature DB >> 2728857

Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986).

M Giagheddu1, G Puggioni, G Sanna, G Tamburini, F Marrosu, M G Rachele, B Murgia, G Rosati.   

Abstract

From 1.1.1958 to 31.12.1986, 110 cases of MG were observed in Sardinia, with a mean annual incidence of 2.5 x 1,000,000 inhabitants and prevalence rates of 7.5, 17.6, 31.4 and 45.0 x 1,000,000 inhabitants respectively (prevalence days: 15.10.1961, 24.10.1971, 25.10.1981 and 31.12.1986). The disease was found to be more frequent in women. There were no differences in the distribution of MG in various areas of the island. The muscle group more frequently involved at onset was the ocular. In 6.4% of patients an association with thyroid disorders was observed. The mortality of MG patients was significantly higher than expected. Removal of the thymus, carried out in 58 patients, was shown to be useful in the treatment of the disease, particularly in patients without thymomas. No familial cases were observed.

Entities:  

Mesh:

Year:  1989        PMID: 2728857     DOI: 10.1111/j.1600-0404.1989.tb03793.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Nationwide population-based epidemiological study of myasthenia gravis in taiwan.

Authors:  Chien-Hsu Lai; Hung-Fu Tseng
Journal:  Neuroepidemiology       Date:  2010-06-03       Impact factor: 3.282

Review 2.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

3.  Epidemiology of seropositive myasthenia gravis in Greece.

Authors:  K Poulas; E Tsibri; A Kokla; D Papanastasiou; T Tsouloufis; M Marinou; P Tsantili; T Papapetropoulos; S J Tzartos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

4.  Mortality and survival in myasthenia gravis: a Danish population based study.

Authors:  P B Christensen; T S Jensen; I Tsiropoulos; T Sørensen; M Kjaer; E Højer-Pedersen; M J Rasmussen; E Lehfeldt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

5.  Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.

Authors:  N P Robertson; J Deans; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

6.  Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy.

Authors:  D Guidetti; R Sabadini; M Bondavalli; S Cavalletti; M Lodesani; R Mantegazza; V Cosi; F Solime
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

7.  Myasthenia gravis associated with Charcot-Marie-Tooth neuropathy: report of a case.

Authors:  G Salemi; B Fierro; G Savettieri; M Maggio; I Lupo; S Ferrari; F Piccoli
Journal:  Ital J Neurol Sci       Date:  1992-06

8.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

9.  Incidence of thymoma in myasthenia gravis: a systematic review.

Authors:  Zhi-Feng Mao; Xue-An Mo; Chao Qin; Yong-Rong Lai; Maree L Hackett
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.